These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34119640)

  • 1. Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis.
    Schoenberger H; Chong N; Fetzer DT; Rich NE; Yokoo T; Khatri G; Olivares J; Parikh ND; Yopp AC; Marrero JA; Singal AG
    Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1561-1569.e4. PubMed ID: 34119640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.
    Simmons O; Fetzer DT; Yokoo T; Marrero JA; Yopp A; Kono Y; Parikh ND; Browning T; Singal AG
    Aliment Pharmacol Ther; 2017 Jan; 45(1):169-177. PubMed ID: 27862091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness Analysis of Hepatocellular Carcinoma Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis Using US Visualization Score C-Triggered Abbreviated MRI.
    Mulgaonkar A; Huang DQ; Siddiqi H; Fowler K; Sirlin CB; Marks R; Loomba R; Konijeti GG
    Am J Gastroenterol; 2024 Jul; 119(7):1326-1336. PubMed ID: 38146873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCC screening with ultrasound: assessment of quality using ultrasound LI-RADS score.
    King MJ; Lee KM; Rosberger S; Huang HH; Meza GH; Lewis S; Taouli B
    Abdom Radiol (NY); 2023 Jan; 48(1):263-270. PubMed ID: 36243829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study.
    Chong N; Schoenberger H; Yekkaluri S; Fetzer DT; Rich NE; Yokoo T; Gopal P; Manwaring C; Quirk L; Singal AG
    Aliment Pharmacol Ther; 2022 Mar; 55(6):683-690. PubMed ID: 35170052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of advanced hepatic fibrosis and sonographic visualization score: a dual-center study using ACR US LI-RADS.
    Choi HH; Perez MG; Millet JD; Liang T; Wasnik AP; Maturen KE; Kamaya A
    Abdom Radiol (NY); 2019 Apr; 44(4):1415-1422. PubMed ID: 30539252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound LI-RADS Visualization Scores on Surveillance Ultrasound for Hepatocellular Carcinoma: A Systematic Review With Meta-analysis.
    Kang JH; Kim NH; Kim DH; Choi Y; Choi JI
    Ultrasound Med Biol; 2023 Oct; 49(10):2205-2212. PubMed ID: 37517886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter Study of ACR Ultrasound LI-RADS Visualization Scores on Serial Examinations: Implications for Surveillance Strategies.
    Tiyarattanachai T; Fetzer DT; Kamaya A
    AJR Am J Roentgenol; 2022 Sep; 219(3):445-452. PubMed ID: 35383486
    [No Abstract]   [Full Text] [Related]  

  • 9. Follow Up Imaging in Hepatocellular Cancer Ultrasound Screening Exams With Poor Visualization Scores.
    Bley E; Mohan N; Jackson I; Chaisidhivej N; Jarrett S; Lo KB; Navarro V; Rossi S; Rodgers SK; Kalman RS
    J Ultrasound Med; 2022 Dec; 41(12):3113-3118. PubMed ID: 36063062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study.
    Huang DQ; Fowler KJ; Liau J; Cunha GM; Louie AL; An JY; Bettencourt R; Jung J; Gitto Z; Hernandez C; Lopez SJ; Gupta H; Sirlin CB; Marks RM; Loomba R
    Aliment Pharmacol Ther; 2022 Apr; 55(7):820-827. PubMed ID: 35229334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Ultrasound LI-RADS Visualization Score With Examination, Sonographer, and Radiologist Factors: Retrospective Assessment in Over 10,000 Examinations.
    Fetzer DT; Browning T; Xi Y; Yokoo T; Singal AG
    AJR Am J Roentgenol; 2022 Jun; 218(6):1010-1020. PubMed ID: 34910539
    [No Abstract]   [Full Text] [Related]  

  • 12. Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Aby E; Phan J; Truong E; Grotts J; Saab S
    J Clin Gastroenterol; 2019 Feb; 53(2):142-146. PubMed ID: 29912761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality Assessment of Ultrasound and Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: A Systematic Review and Meta-Analysis.
    Quek J; Tan DJH; Chan KE; Lim WH; Ng CH; Ren YP; Koh TK; Teh R; Xiao J; Fu C; Syn N; Teng M; Muthiah M; Fowler KJ; Sirlin CB; Loomba R; Huang DQ
    Dig Dis; 2023; 41(5):757-766. PubMed ID: 37231918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound Liver Imaging Reporting and Data System (US LI-RADS) Visualization Score: a reliability analysis on inter-reader agreement.
    Tiyarattanachai T; Bird KN; Lo EC; Mariano AT; Ho AA; Ferguson CW; Chima RS; Desser TS; Morimoto LN; Kamaya A
    Abdom Radiol (NY); 2021 Nov; 46(11):5134-5141. PubMed ID: 34228197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic value of contrast-enhanced ultrasound LI-RADS for hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis B.
    Yang D; Hu H; Li R; Tang CL; Ma KS; Guo DY
    Abdom Radiol (NY); 2022 Feb; 47(2):630-639. PubMed ID: 34910237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score.
    Park MK; Lee DH; Hur BY; Lee HC; Lee YB; Yu SJ; Kim YJ; Yoon JH; Lee JH
    Radiology; 2023 Jun; 307(5):e222106. PubMed ID: 37249427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS Classification.
    Smereka P; Doshi AM; Lavelle LP; Shanbhogue K
    AJR Am J Roentgenol; 2020 Aug; 215(2):382-389. PubMed ID: 32432909
    [No Abstract]   [Full Text] [Related]  

  • 19. Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI-RADS v2018.
    Khatri G; Pedrosa I; Ananthakrishnan L; de Leon AD; Fetzer DT; Leyendecker J; Singal AG; Xi Y; Yopp A; Yokoo T
    J Magn Reson Imaging; 2020 Feb; 51(2):415-425. PubMed ID: 31209978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound Liver Imaging Reporting and Data System (US LI-RADS): An Overview with Technical and Practical Applications.
    Choi HH; Rodgers SK; Fetzer DT; Wasnik AP; Millet JD; Morgan TA; Dawkins A; Gabriel H; Kamaya A
    Acad Radiol; 2021 Oct; 28(10):1464-1476. PubMed ID: 32718745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.